Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.

AUR-105 by Aurigene Oncology for Leukemia: Likelihood of Approval

AUR-105 is under clinical development by Aurigene Oncology and currently in Phase I for Leukemia.

January 25, 2024

Towards xenotransplantation: Genetically altered pig kidneys prove viable in non-human primates

Researchers used a genetically engineered porcine donor to develop kidney grafts.

October 11, 2023

Eye Injuries From Fireworks Greater in Areas Where They Are Legal

The chances of eye injuries from fireworks were slightly higher among residents of areas where fireworks were legal compared with residents of areas where fireworks

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.